Deals this week: SetPoint Medical Corporation, Zhuhai Hokai Medical Instruments, MedGenome


US-based biomedical technology company SetPoint Medical Corporation has raised $30m in a Series D financing round led by New Enterprise Associates.

The company plans to use the funds to advance the development of its bioelectronic therapy for inflammatory diseases.

Chinese company Zhuhai Hokai Medical Instruments Co Ltd plans to raise CNY1bn ($150.1m) through the public offering of convertible bonds due in 2023.

"The company plans to use the funds to advance the development of its bioelectronic therapy for inflammatory diseases."

US-based genomics research and diagnostics company MedGenome Inc has secured $30m in a Series C venture financing round led by Sequoia Capital India Advisors Pvt Ltd.

The company intends to use the stocks to progress its biomarker discovery programmes.